AORT
ARTIVION, INC.
NYSE · Healthcare · Medical - Devices · US
$23.35
−2.22%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.11
- Revenue estimate
- $120.9M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.28
- EPS estimate
- $0.00
- Revenue actual
- $125.8M
- Revenue estimate
- $120.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -2807.7%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $42
- PT range
- $40 – $44
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.00 | -$0.28 | Miss -11300.00% | $125.8M |
| May 7, 2026 | $0.06 | $0.08 | Beat 33.33% | $116.3M |
| Feb 12, 2026 | $0.14 | $0.17 | Beat 21.43% | $116.0M |
| Nov 6, 2025 | $0.14 | $0.16 | Beat 14.29% | $113.4M |
| Aug 7, 2025 | $0.11 | $0.24 | Beat 118.18% | $113.0M |
| Nov 7, 2024 | $0.10 | $0.12 | Beat 20.63% | $95.8M |
| Aug 8, 2024 | -$0.49 | $0.07 | Beat 114.32% | $98.0M |
| Feb 15, 2024 | -$0.13 | $0.11 | Beat 184.62% | $93.7M |
| Nov 2, 2023 | -$0.01 | $0.02 | Beat 313.90% | $87.9M |
| Aug 3, 2023 | $0.06 | $0.06 | Beat 7.89% | $89.3M |
| May 4, 2023 | -$0.07 | $0.02 | Beat 127.59% | $83.2M |
| Feb 16, 2023 | -$0.17 | $0.10 | Beat 158.82% | $79.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026